Inhaled corticosteroids (ICSs) are indicated for the prevention of exacerbations in COPD;
however, a significant proportion of patients at low risk of exacerbations are treated with …

Background Anti-type 2 inflammation therapy has been proposed as a treatment strategy for
eosinophil-associated chronic airway disorders that could reduce exacerbations and …

Introduction As of today, there is still a need to determine which COPD patients may benefit
from ICS therapy, whether ICSs are useful in COPD patients without chronic bronchitis, and …

Background The effect of inhaled corticosteroids (ICS) on risk of hyperglycemia in patients
with chronic obstructive pulmonary disease (COPD) remains ambiguous. The aim of this …

Antibiotics can improve the prognosis in patients with exacerbation of chronic obstructive
pulmonary disease. However, the overuse of antibiotics can carry serious adverse effects for …

This study reports the association of ICS use and the risk of type 2 diabetes mellitus (T2DM)
in Swedish patients with COPD using data from real-world, primary care settings. A total of …

Treating patients hospitalised with acute exacerbations of chronic obstructive pulmonary
disease (COPD) usually involves administering systemic corticosteroids. The many …

Does inhaled corticosteroid use affect the risk of COVID-19-related death? | European
Respiratory Society Skip to main content Main menu Home Current issue Past issues …

Background The prevalence of both asthma and early-onset diabetes is on the rise;
however, the association between them remains unclear. We examined a possible …

Introduction Treatment with inhaled corticosteroids (ICS) is a widely used treatment in
chronic obstructive pulmonary disease. The main effects include a reduction in the number …